{
    "organizations": [],
    "uuid": "bcfc695ef3d4995ea7f2d1c64d51751302b721b5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-isr-starts-two-new-programs-agains/brief-isr-starts-two-new-programs-against-tbc-and-cancer-idUSFWN1PH041",
    "ord_in_thread": 0,
    "title": "BRIEF-ISR Starts Two New Programs Against TBC And Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL):\n* ISR IMMUNE SYSTEM REGULATION HOLDING AB STARTS TWO NEW PROGRAMS AGAINST TBC AND CANCER\n* PLANS TO INITIATE A PHASE I SAFETY STUDY IN HUMANS DURING FALL OF 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-22T15:40:00.000+02:00",
    "crawled": "2018-01-23T17:50:00.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "isr",
        "immune",
        "system",
        "regulation",
        "holding",
        "ab",
        "publ",
        "isr",
        "immune",
        "system",
        "regulation",
        "holding",
        "ab",
        "start",
        "two",
        "new",
        "program",
        "tbc",
        "cancer",
        "plan",
        "initiate",
        "phase",
        "safety",
        "study",
        "human",
        "fall",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}